Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Clear-cell Renal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00422786
What this trial is testing

Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Thallion Pharmaceuticals 10
Testing effectiveness (Phase 2)Study completedNCT00378703
What this trial is testing

Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7
National Cancer Institute (NCI) 361
Testing effectiveness (Phase 2)Study completedNCT03294083
What this trial is testing

Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
SillaJen, Inc. 95
Testing effectiveness (Phase 2)UnknownNCT06221774
What this trial is testing

Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors

Who this might be right for
Clear Cell Renal CarcinomaUrothelial CarcinomaMetastatic Castration-resistant Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 42
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Looking for participantsNCT03866382
What this trial is testing

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Who this might be right for
Bladder AdenocarcinomaBladder Clear Cell AdenocarcinomaBladder Mixed Adenocarcinoma+42 more
National Cancer Institute (NCI) 314
Very early researchStudy completedNCT00276835
What this trial is testing

Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
Northwestern University 15
Testing effectiveness (Phase 2)UnknownNCT00293501
What this trial is testing

Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney Cancer
University of Vermont 35
Not applicableEnded earlyNCT01599832
What this trial is testing

Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
University of Chicago 20
Testing effectiveness (Phase 2)Study completedNCT00830895
What this trial is testing

RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Seoul National University Hospital 49
Testing effectiveness (Phase 2)Study completedNCT01775930
What this trial is testing

Carfilzomib in Refractory Renal Cell Carcinoma (RCC)

Who this might be right for
Kidney Cancer
M.D. Anderson Cancer Center 10
Early research (Phase 1)Ended earlyNCT00589550
What this trial is testing

PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Thomas Olencki 1
Testing effectiveness (Phase 2)Study completedNCT00276614
What this trial is testing

Bortezomib in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Jonsson Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT03494816
What this trial is testing

Study of Axitinib for Reducing Extent of Venous Tumour Thrombus in Renal Cancer With Venous Invasion

Who this might be right for
Renal Cell CarcinomaMetastatic Renal Cell CarcinomaNon-metastatic Renal Cell Carcinoma
Scottish Clinical Trials Research Unit 24
Testing effectiveness (Phase 2)Looking for participantsNCT07227415
What this trial is testing

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Who this might be right for
Carcinoma, Renal CellAdvanced Renal Cell CarcinomaRenal Cancer+10 more
Pfizer 224
Early research (Phase 1)Looking for participantsNCT07564232
What this trial is testing

Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT00226798
What this trial is testing

Immunochemotherapy for Metastatic Renal Cell Carcinoma

Who this might be right for
Adenocarcinoma Clear Cell
Rambam Health Care Campus 45
Not applicableLooking for participantsNCT06676527
What this trial is testing

Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma

Who this might be right for
NeoplasmsKidney NeoplasmsUrologic Neoplasms+10 more
Jinling Hospital, China 39
Testing effectiveness (Phase 2)Study completedNCT01727089
What this trial is testing

Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer+2 more
National Cancer Institute (NCI) 59
Testing effectiveness (Phase 2)Looking for participantsNCT06413680
What this trial is testing

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Who this might be right for
MelanomaClear-Cell Renal-Cell Carcinoma (ccRCC)Advanced Solid Tumors
Regeneron Pharmaceuticals 240
Next Page